That is the title of an interview with me in The Evidence Base out today with the subtitle Introducing generalized cost effectiveness analysis for a comprehensive value assessment. Below is an excerpt: What is this paper about? What is new in this paper?Our recent publication presents a comprehensive framework for evaluating the societal value of health technologies,…
This brief analyzes federal transparency data released by the Centers for Medicare and Medicaid Services (CMS) on claims denials and appeals for non-group qualified health plans (QHPs) offered on HealthCare.gov in 2023. It finds that HealthCare.gov insurers denied nearly one out of every five claims (19%) submitted for in-network services. Information about the reasons for…
Expert notes that insurance coverage remains poor for obesity as a medical condition
While more large employers are covering GLP-1 drugs for weight loss, KFF’s conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in some cases, employers are adding or strengthening coverage requirements.
Last month, Planned Parenthood Great Plains opened its newest clinic in Pittsburg, Kan., a city of about 21,000 people mere minutes from the borders of both Missouri and Oklahoma. It’s the second new clinic the regional affiliate has opened in Kansas in a little over two years, to accommodate the growing number of patients coming…
With Sunrise’s women’s health program, the company can support women battling sleep issues due to conditions like pregnancy, polycystic ovary syndrome, perimenopause, menopause and premenstrual syndrome. The post Sunrise Introduces Sleep Offering Tailored to Women appeared first on MedCity News.
An expanded partnership with Humana will help Aledade’s FQHC and rural health clinic partners share savings in Medicare Advantage. The post Aledade, Humana Expand Value-Based Partnership to Support FQHCs and Rural Health Clinics appeared first on MedCity News.
Ionis Pharmaceuticals plans a 2026 FDA submission for zilganersen as a treatment for Alexander disease, an ultra-rare inherited neurological disorder. The antisense oligonucleotide developer has been moving toward commercializing drugs on its own rather than seeking partners. The post Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study appeared…
At a recent conference, Maria Berkman — who serves as head of medtech at Broadview Ventures and managing director at Longview Ventures — shared insights into the somewhat niche ecosystem of medtech investment. The post 3 Things to Know About Medtech Investment, From a VC appeared first on MedCity News.
Justin Schrager is the CMO of Vital.io. Their technology sits in the hospital telling patients what is going on with their care while they are in the hospital, particularly in the ER. Justin showed a deep demo about the patient experience of using Vital.io which includes what the patient can expect and guides them through…